HealthEquity (NASDAQ:HQY) EVP Delano Ladd Sells 7,500 Shares of Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Delano Ladd sold 7,500 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Stock Up 3.0%

HealthEquity stock opened at $90.64 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The company’s 50-day moving average is $83.63 and its 200-day moving average is $86.61. The firm has a market capitalization of $7.58 billion, a PE ratio of 33.95, a P/E/G ratio of 1.60 and a beta of 0.21. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts anticipate that HealthEquity, Inc. will post 3.84 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Royal Bank Of Canada lifted their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Friday. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research note on Monday. Citizens Jmp upped their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research note on Monday. Raymond James Financial set a $100.00 price objective on shares of HealthEquity in a research report on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $111.53.

Institutional Investors Weigh In On HealthEquity

Hedge funds have recently made changes to their positions in the stock. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the fourth quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new stake in shares of HealthEquity during the 4th quarter valued at $28,000. Leonteq Securities AG boosted its holdings in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC bought a new stake in HealthEquity during the 1st quarter worth $33,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.